Factors associated with left ventricular reverse remodelling after percutaneous coronary intervention in patients with left ventricular systolic dysfunction

被引:0
|
作者
Yusuke Adachi
Arihiro Kiyosue
Jiro Ando
Takuya Kawahara
Satoshi Kodera
Shun Minatsuki
Hironobu Kikuchi
Toshiro Inaba
Hiroyuki Kiriyama
Kazutoshi Hirose
Hiroki Shinohara
Akihito Saito
Takayuki Fujiwara
Hironori Hara
Kazutaka Ueda
Kenichi Sakakura
Masaru Hatano
Mutsuo Harada
Eiki Takimoto
Hiroshi Akazawa
Hiroyuki Morita
Shin-ichi Momomura
Hideo Fujita
Issei Komuro
机构
[1] The University of Tokyo,Department of Cardiovascular Medicine, Graduate School of Medicine
[2] The University of Tokyo Hospital,Clinical Research Promotion Center
[3] Saitama Medical Center,Division of Cardiovascular Medicine
[4] Jichi Medical University,Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine
[5] The University of Tokyo,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Percutaneous coronary intervention (PCI) is sometimes considered as an alternative therapeutic strategy to surgical revascularization in patients with coronary artery disease (CAD) and reduced left ventricular ejection fraction (LVEF). However, the types or conditions of patients that receive the clinical benefit of left ventricular reverse remodelling (LVRR) remain unknown. The purpose of this study was to investigate the determinants of LVRR following PCI in CAD patients with reduced LVEF. From 4394 consecutive patients who underwent PCI, a total of 286 patients with reduced LV systolic function (LVEF < 50% at initial left ventriculography) were included in the analysis. LVRR was defined as LV end-systolic volume reduction ≥ 15% and improvement of LVEF ≥ 10% at 6 months follow-up left ventriculography. Patients were divided into LVRR (n = 63) and non-LVRR (n = 223) groups. Multivariate logistic regression analysis revealed that unprotected left main coronary artery (LMCA) intervention was significantly associated with LVRR (P = 0.007, odds ratios [OR] 4.70, 95% confidence interval [CI] 1.54–14.38), while prior PCI (P = 0.001, OR 0.35, 95% CI 0.19–0.66), presence of in-stent restenosis (P = 0.016, OR 0.32, 95% CI 0.12–0.81), and presence of de-novo stenosis (P = 0.038, OR 0.36, 95% CI 0.14–0.95) were negatively associated with LVRR. These data suggest the potential prognostic benefit of unprotected LMCA intervention for LVRR and importance of angiographic follow-up in patients with CAD and LV systolic dysfunction.
引用
收藏
相关论文
共 50 条
  • [31] Reverse left ventricular remodeling after primary percutaneous coronary intervention for STEMI: prognostic implications
    Carrabba, N.
    Migliorini, A.
    Valenti, R.
    Parodi, G.
    Dovellini, E. V.
    Antoniucci, D.
    EUROPEAN HEART JOURNAL, 2010, 31 : 641 - 641
  • [32] The predictive value of coronary microvascular dysfunction for left ventricular reverse remodelling in dilated cardiomyopathy
    Kan, Ao
    Leng, Yinping
    Li, Shuhao
    Lin, Fang
    Fang, Qimin
    Tao, Xinwei
    Hu, Mengyao
    Gong, Lianggeng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [33] Is There Evidence Supporting Coronary Revascularization in Patients With Left Ventricular Systolic Dysfunction?
    Ammirati, Enrico
    Rimoldi, Ornella E.
    Camici, Paolo G.
    CIRCULATION JOURNAL, 2011, 75 (01) : 3 - 10
  • [34] Hyperglycemia, a biomarker of left ventricular systolic dysfunction in acute coronary patients?
    Castro, A.
    Moreno, N.
    Pereira, A.
    Santos, R.
    Queiros, M. C.
    Pinto, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S185 - S185
  • [35] Microvascular Dysfunction and Left Ventricular Chamber Stiffness after Successful Percutaneous Coronary Intervention Critically Determine Left Ventricular Remodeling in Patients with Acute Myocardial Infarction
    Yamamuro, Atsushi
    Akasaka, Takashi
    Kaji, Shuichiro
    Tamita, Koichi
    Katayama, Minako
    Kinoshita, Makoto
    Ehara, Natsuhiko
    Kobori, Atsushi
    Kitai, Takeshi
    Yamane, Takafumi
    An, Yoshimori
    Kim, Kite
    Funakoshi, Syunsuke
    Kimura, Noriyuki
    Tani, Tomoko
    Tanabe, Kazuaki
    Morioka, Shigefumi
    Furukawa, Yutaka
    CIRCULATION, 2008, 118 (18) : S843 - S843
  • [36] Impact of the Combined Left Ventricular Systolic and Renal Dysfunction on One-Year Outcomes after Primary Percutaneous Coronary Intervention
    Savic, Lidija
    Mrdovic, Igor
    Perunicic, Jovan
    Asanin, Milika
    Lasica, Ratko
    Marinkovic, Jelena
    Vasiljevic, Zorana
    Ostojic, Miodrag
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2012, 25 (02) : 132 - 139
  • [37] Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program
    Brophy, Todd J.
    Warsavage, Theodore J.
    Hebbe, Annika L.
    Plomondon, Mary E.
    Waldo, Stephen W.
    Rao, Sunil V.
    DeVore, Adam D.
    Gutierrez, J. Antonio
    Swaminathan, Rajesh V.
    AMERICAN HEART JOURNAL, 2021, 235 : 149 - 157
  • [38] Left ventricular remodelling pattern and prognostic relevance in patients with STEMI treated with primary percutaneous coronary intervention
    Chimed, S.
    Van Der Bijl, R.
    Lustosa, R.
    Montero, J. M.
    Marsan, N. A.
    Delgado, V
    Bax, J. J.
    EUROPEAN HEART JOURNAL, 2020, 41 : 910 - 910
  • [39] Acute haemodynamic effects of levosimendan after primary percutaneous coronary intervention in patients with severe left ventricular dysfunction
    Proietti, P
    de Luca, L
    Musarò, S
    Celotto, A
    Ruzzolini, M
    Peres, FI
    Fedele, F
    EUROPEAN HEART JOURNAL, 2004, 25 : 30 - 30
  • [40] Effect of Calcium Channel Blockers on Clinical Outcomes in Patients After Percutaneous Coronary Intervention With Left Ventricular Dysfunction
    Uematsu, Manabu
    Nakamura, Takamitsu
    Horikoshi, Takeo
    Kobayashi, Tsuyoshi
    Yoshizaki, Toru
    Nakamura, Jun
    Makino, Aritaka
    Saito, Yukio
    Obata, Jun-Ei
    Sawanobori, Takao
    CIRCULATION, 2023, 148